Biotech Abivax reaches milestone after record stock market year

Abivax posted a record stock market year and is now presenting clinical advances on its flagship Obefazi molecule.

Published 19sem1 sourceNotableupdated 1sem

≈ 21sSpeed

The fact

The French biotech company continues therapeutic development with promising late-stage results.

This progress positions Abivax as a key player in the French listed biotech sector.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on May 5, 2026